Advertisement

Archive

2012: 108/5 (Nov) pp. 801-1007

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Topic:

Theme Issue
European Vascular Biology Meeting 2011 (Part 2)


26 articles
1.
Andrzej Szczeklik
June 29, 1938 – February 3, 2012

J. Dulak, A. Jozkowicz

Thromb Haemost 2012 108 5: V-VI

[Summary] [Free PDF]
2.

J. Dulak (1), T. J. Guzik (2)

(1) Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland; (2) Department of Internal and Agricultural Medicine, Jagiellonian University School of Medicine, J Dietl Hospital, Krakow, Poland

Thromb Haemost 2012 108 5: 801-803

https://doi.org/10.1160/TH12-10-0729

[Summary] [Free PDF] [Export citation]
3.

E. Pardali (1), J. Waltenberger (1)

(1) Department Cardiovascular Medicine, University of Münster, Münster, Germany

Thromb Haemost 2012 108 5: 804-811

https://doi.org/10.1160/TH12-04-0276

[Summary] [Free PDF] [Export citation]
4.

Online Supplementary Material

A. Sagan (1), W. Mrowiecki (2), T. P. Mikolajczyk (1), K. Urbanski (1), M. Siedlinski (1), R. Nosalski (1), R. Korbut (3), T. J. Guzik (4)

(1) Translational Medicine Laboratory, Department of Internal and Agricultural Medicine, Jagiellonian University School of Medicine, Kraków, Poland; (2) Department of Surgery, J Grande Hospital, Kraków, Poland; (3) Department of Pharmacology, Jagiellonian University School of Medicine, Kraków, Poland; (4) Department of Internal and Agricultural Medicine, Jagiellonian University School of Medicine, J Dietl Hospital, Krakow, Poland

Thromb Haemost 2012 108 5: 812-823

https://doi.org/10.1160/TH12-05-0339

[Summary] [Free PDF] [Export citation]
5.

Online Supplementary Material

W. N. Nowak (1, 2), P. Mika (3), R. Nowobilski (4), K. Kusinska (1), K. Bukowska-Strakova (1, 2), R. Nizankowski (5), A. Józkowicz (1), A. Szczeklik (5), J. Dulak (1)

(1) Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland; (2) Jagiellonian Centre for Experimental Therapeutics, Jagiellonian University, Krakow, Poland; (3) Department of Clinical Rehabilitation, University School of Physical Education, Krakow, Poland; (4) Institute of Physiotherapy, Faculty of Health Sciences, Jagiellonian University, Krakow, Poland; (5) 2nd Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland

Thromb Haemost 2012 108 5: 824-831

https://doi.org/10.1160/TH12-04-0278

[Summary] [Free PDF] [Export citation]
6.

E. McNeill (1, 2), K. Channon (1, 2)

(1) Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK; (2) Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK

Thromb Haemost 2012 108 5: 832-839

https://doi.org/10.1160/TH12-06-0424

[Summary] [Free PDF] [Export citation]
7.

A. S. Antonopoulos (1), M. Margaritis (1), C. Shirodaria (1), C. Antoniades (1)

(1) Department of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom

Thromb Haemost 2012 108 5: 840-848

https://doi.org/10.1160/TH12-05-0337

[Summary] [Free PDF] [Export citation]
8.

Online Supplementary Material

A. Petry (1), R. S. BelAiba (1), M. Weitnauer (1), A. Görlach (1, 2)

(1) Experimental and Molecular Pediatric Cardiology, German Heart Center Munich at the Technical University Munich, Munich, Germany; (2) Munich Heart Alliance, Munich, Germany

Thromb Haemost 2012 108 5: 849-862

https://doi.org/10.1160/TH12-04-0277

[Summary] [Free PDF] [Export citation]
9.

I. L. A. Geenen (1, 2), M. J. Post (1), D. G. M. Molin (1), G. W. H. Schurink (2), J. G. Maessen (3), R. v. Oerle (4), H. ten Cate (4), H. M. H. Spronk (4)

(1) Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands; (2) Department of General Surgery, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands; (3) Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands; (4) Department of Internal Medicine, Laboratory of Clinical Thrombosis and Haemostasis, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands

Thromb Haemost 2012 108 5: 863-871

https://doi.org/10.1160/TH12-04-0269

[Summary] [Free PDF] [Export citation]
10.

Editorial Focus on Harenberg et al.

S. Schulman (1)

(1) Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada

Thromb Haemost 2012 108 5: 872-875

https://doi.org/10.1160/TH12-10-0730

[Summary] [Free PDF] [Export citation]
11.

A. G. G. Turpie (1), R. Kreutz (2), J. Llau (3), B. Norrving (4), S. Haas (5)

(1) Department of Medicine, McMaster University, Hamilton, Ontario, Canada; (2) Institute of Clinical Pharmacology and Toxicology, Charité, Universitätsmedizin, Berlin, Germany; (3) Department of Anaesthesiology and Critical Care, Hospital Clínico, Valencia, Spain; (4) Department of Clinical Neuroscience, Lund University Hospital, Lund, Sweden; (5) Institute for Experimental Oncology and Therapy Research, Technical University of Munich, Germany

Thromb Haemost 2012 108 5: 876-886

https://doi.org/10.1160/TH12-03-0209

[Summary] [Free PDF] [Export citation]
12.

Online Supplementary Material

S. Rohatagi (1), J. Mendell (2), H. Kastrissios (3), M. Green (3), M. Shi (2), I. Patel (2), D. E. Salazar (2)

(1) Daiichi Sankyo India Pharma Private Ltd, Mumbai, India; (2) Daiichi Sankyo Pharma Development, Edison, New Jersey, USA; (3) Pharsight Corporation, Mountain View, California, USA

Thromb Haemost 2012 108 5: 887-895

https://doi.org/10.1160/TH12-03-0184

[Summary] [PDF] [Pay per view] [Export citation]
13.

T. Funatsu (1), A. Yamashita (2), S. Kaku (1), Y. Iwatsuki (1), Y. Asada (2)

(1) Applied Pharmacology Research Laboratories, Ibaraki, Japan; (2) Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan

Thromb Haemost 2012 108 5: 896-902

https://doi.org/10.1160/TH12-04-0267

[Summary] [PDF] [Pay per view] [Export citation]
14.

See also Editorial Focus by Schulman

J. Harenberg (1), S. Marx (1), O. E. Dahl (2), V. J. Marder (3), A. Schulze (4), M. Wehling (1), C. Weiss (5)

(1) Department of Clinical Pharmacology, Medical Faculty Mannheim, Ruprecht-Karls-University Heidelberg, Mannheim, Germany; (2) Department of Orthopaedics, Innlandet Hospital Trust, Elverum, Norway; (3) Division of Haematology/Medical Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA; (4) Center for Orthopedic and Trauma Surgery, Medical Faculty Mannheim, Ruprecht-Karls-University Heidelberg, Mannheim, Germany; (5) Biometry and Statistics, Medical Faculty Mannheim, Ruprecht-Karls-University Heidelberg, Mannheim, Germany

Thromb Haemost 2012 108 5: 903-912

https://doi.org/10.1160/TH12-07-0482

[Summary] [PDF] [Pay per view] [Export citation]
15.

Online Supplementary Material

J. Powell (1), U. Martinowitz (2), J. Windyga (3), G. Di Minno (4), A. Hellmann (5), I. Pabinger (6), M. Maas Enriquez (7), L. Schwartz (8), J. Ingerslev (9), the LipLong Study Investigators

(1) Division of Hematology/Oncology, School of Medicine, University of California at Davis, Davis, California, USA; (2) The National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel; (3) Department of Disorders of Haemostasis and Internal Medicine, Institute of Haematology and Transfusion Medicine, Warsaw, Poland; (4) Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University Hospital, Naples, Italy; (5) Department of Hematology, Medical University of Gdansk/Poland; (6) Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University Vienna, Austria; (7) Bayer Pharma AG, Wuppertal, Germany; (8) Bayer HealthCare Pharmaceuticals Inc., Montville, New Jersey, USA; (9) Center for Haemophilia and Thrombosis, Aarthus University Hospital, Skejby, Denmark

Thromb Haemost 2012 108 5: 913-922

https://doi.org/10.1160/TH12-03-0188

[Summary] [PDF] [Pay per view] [Export citation]
16.
Lipid levels do not influence the risk of venous thromboembolism
Results of a population-based cohort study

I. M. van Schouwenburg (1), B. K. Mahmoodi (2, 1), R. T. Gansevoort (2), F. L. H. Muntinghe (3), R. P. F. Dullaart (4), H. C. Kluin-Nelemans (1), N. J. G. M. Veeger (1, 5), K. Meijer (1)

(1) Division of Haemostasis and Thrombosis, Department of Haematology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands; (2) Department of Nephrology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands; (3) Department of Vascular Medicine, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands; (4) Department of Endocrinology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands; (5) Trial Coordination Centre, Department of Epidemiology, University of Groningen, University Medical Centre Groningen, The Netherlands

Thromb Haemost 2012 108 5: 923-929

https://doi.org/10.1160/TH12-06-0426

[Summary] [PDF] [Pay per view] [Export citation]
17.

S. Suryadevara (1), M. Ueno (1), A. Tello-Montoliu (1), J. L. Ferreiro (1), B. Desai (1), F. Rollini (1), L. C. Box (1), M. Zenni (1), L. A. Guzman (1), T. A. Bass (1), D. J. Angiolillo (1)

(1) University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA

Thromb Haemost 2012 108 5: 930-936

https://doi.org/10.1160/TH12-06-0397

[Summary] [PDF] [Pay per view] [Export citation]
18.
Thrombus and antiplatelet therapy in type 2 diabetes mellitus
A prospective study after non-ST elevation acute coronary syndrome and a randomised, blinded, placebo-controlled study in stable angina

G. N. Viswanathan (1), S. M. Marshall (1), C. B. Schechter (2), K. Balasubramaniam (1), J. J. Badimon (3), A. G. Zaman (1, 4)

(1) Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK; (2) Albert Einstein College of Medicine, New York, New York, USA; (3) Atherothrombosis Research Unit, Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA; (4) Freeman Hospital, Newcastle upon Tyne Hospitals NHS TRust, Newcastle upon Tyne, UK

Thromb Haemost 2012 108 5: 937-945

https://doi.org/10.1160/TH12-06-0408

[Summary] [PDF] [Pay per view] [Export citation]
19.

S. Enayat (1), S. Ravanbod (1), M. Rassoulzadegan (1), M. Jazebi (1), S. Tarighat (1), F. Ala (1), J. Emsley (2), M. Othman (3)

(1) Iranian Comprehensive Haemophilia Care Centre, Tehran, Islamic Republic of Iran; (2) School of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, UK; (3) Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, Ontario, Canada

Thromb Haemost 2012 108 5: 946-954

https://doi.org/10.1160/TH12-04-0189

[Summary] [PDF] [Pay per view] [Export citation]
20.

Online Supplementary Material

A. Borgognone (1), F. M. Pulcinelli (1)

(1) Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

Thromb Haemost 2012 108 5: 955-962

https://doi.org/10.1160/TH12-04-0232

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-26